Stratec Biomedical AG (SBS) – Research Analysts’ Recent Ratings Updates

Stratec Biomedical AG (ETR: SBS) recently received a number of ratings updates from brokerages and research firms:

  • 10/30/2017 – Stratec Biomedical AG was given a new €59.00 ($68.60) price target on by analysts at Berenberg Bank. They now have a “neutral” rating on the stock.
  • 10/27/2017 – Stratec Biomedical AG was given a new €70.00 ($81.40) price target on by analysts at Kepler Capital Markets. They now have a “buy” rating on the stock.
  • 10/26/2017 – Stratec Biomedical AG was given a new €62.00 ($72.09) price target on by analysts at Warburg Research. They now have a “buy” rating on the stock.
  • 10/24/2017 – Stratec Biomedical AG was given a new €56.00 ($65.12) price target on by analysts at Deutsche Bank AG. They now have a “neutral” rating on the stock.
  • 10/23/2017 – Stratec Biomedical AG was given a new €58.00 ($67.44) price target on by analysts at Oddo Bhf. They now have a “neutral” rating on the stock.
  • 10/23/2017 – Stratec Biomedical AG was given a new €57.00 ($66.28) price target on by analysts at Berenberg Bank. They now have a “neutral” rating on the stock.

Shares of Stratec Biomedical AG (SBS) traded up €2.29 ($2.66) during trading on Tuesday, reaching €64.00 ($74.42). 16,917 shares of the company’s stock traded hands, compared to its average volume of 17,645. Stratec Biomedical AG has a 12-month low of €41.30 ($48.02) and a 12-month high of €65.33 ($75.97).

STRATEC Biomedical AG designs and manufactures solutions for automated processes in the fields of in vitro diagnostics and life sciences. The company operates through two segments, Instrumentation and All Other segments. It offers instrumentation products, such as automated analyzer systems, including THOLOS VMI-100, GEMINI, and GEMINI Combo for use in clinical diagnostics and biotechnology to laboratories, blood banks, and research institutes.

Receive News & Ratings for Stratec Biomedical AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stratec Biomedical AG and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply